<?xml version="1.0" encoding="UTF-8"?>
<p id="Par23">Adrenoyl-EA is structurally similar to the major endocannabinoid anandamide and functions as an agonist of the CB
 <sub>1</sub> and TRPV
 <sub>1</sub> receptor proteins, two major receptors of the human ECS [
 <xref ref-type="bibr" rid="CR21">21</xref>, 
 <xref ref-type="bibr" rid="CR24">24</xref>]. Agonists of these receptors are ideal candidates in a range of therapeutic targets, specifically exhibiting anti-inflammatory, neuroprotective, and anticancer activities, among others [
 <xref ref-type="bibr" rid="CR23">23</xref>, 
 <xref ref-type="bibr" rid="CR25">25</xref>, 
 <xref ref-type="bibr" rid="CR26">26</xref>]. Within the growing market of TMs, we consider it beneficial to identify sustainable, climate resilient plant resources (high yielding medicinal crops) that accumulate pCBs or PCB-like compounds with the potential for therapeutic purposes.
</p>
